David Jones
DPhil Student
David joined HERC as a Researcher in October 2016. He has worked on a variety of projects spanning multiple disease areas and methodologies, ranging from the use of expert elicitation to identify diagnostic pathways in non-alcoholic fatty liver disease to within trial analysis of phase 3 randomised trials in oncology.
In his DPhil project, David seeks to continue his work on the comparative assessment of new advanced radiotherapy technologies. This will be done through the development of microsimulation models as well as trial and registry data analysis across a variety of cancer sites.
David's academic background is in Economics, receiving his Bachelor’s Degree in the subject from the University of York. He continued at the University, completing a Master’s Degree in Health Economics with support from a National Institute of Health Research studentship. Prior to joining HERC David worked as a Health Economist Intern at The Global Fund in Geneva. His research looked at estimating the effect of Human Rights interventions on the health and behaviour of marginal population groups in low and middle income countries.
Recent publications
Influence of stage at cancer diagnosis on NHS hospital care costs in England: a national, retrospective, population-based cohort study using individual patient-level data.
Journal article
Pearson C. et al, (2026), Lancet Oncol
Modelled impact of a multi-cancer early detection screening programme on the demand for diagnostics in England
Journal article
Martin J. et al, (2026), British Journal of Cancer
Inequalities in geographic barriers and patient representation in lymphoma clinical trials across England.
Journal article
Jones DA. et al, (2025), Br J Haematol, 206, 531 - 540
Individualised Estimation of Quality-adjusted Survival Benefit and Cost-effectiveness of Proton Beam Therapy in Intermediate-stage Hodgkin Lymphoma.
Journal article
Jones DA. et al, (2023), Clin Oncol (R Coll Radiol), 35, 301 - 310
P095: Personalised Modelling of Quality-Adjusted Survival Benefit and Cost-Effectiveness of using Proton Beam Therapy inthe Treatment of Intermediate-Stage Hodgkin Lymphoma in England
Journal article
Jones D. et al, (2022), HemaSphere, 6, 43 - 44

